康希诺生物 (06185.HK)

+ 收藏

利润表(康希诺生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
起始日期 2023-01-012023-01-012023-01-012022-01-012022-01-012022-01-012022-01-01
截止日期 2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 1231123112311231123112311231
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
原始币种 人民币人民币人民币人民币人民币人民币人民币
营业收入计算(元) 175,631,799.9021,086,000.00100,553,000.001,031,041,000.00707,395,000.00629,790,000.00499,355,000.00
销售成本(元) -172,718,572.70-797,573,000.00-65,187,000.00-1,217,648,000.00-241,686,000.00-313,617,000.00-148,474,000.00
毛利计算(元) 2,913,227.20-776,487,000.0035,366,000.00-186,607,000.00465,709,000.00316,173,000.00350,881,000.00
其他收入(元) 168,390,557.4493,946,000.0051,092,000.00156,937,000.00116,297,000.0076,146,000.0038,777,000.00
销售及分销成本(元) -193,633,711.73-128,844,000.00-54,983,000.00-266,613,000.00-149,135,000.00-88,900,000.00-34,310,000.00
行政开支(元) -188,092,918.68-140,053,000.00-60,547,000.00-278,067,000.00-211,608,000.00-139,630,000.00-64,101,000.00
研发费用(元) -461,673,523.32-338,372,000.00-149,765,000.00-778,257,000.00-549,066,000.00-323,965,000.00-157,155,000.00
其他支出(元) -41,814,507.77-32,363,000.00-8,177,000.00-7,358,000.00-1,396,000.00--1,041,000.00
资产减值损失(元) -801,118,981.81-20,259,000.00-12,873,000.00-8,777,000.00-532,446,000.00-4,624,000.00-6,163,000.00
重估盈余(元) -15,368,509.17-7,169,000.00-5,499,000.00-4,592,000.00
出售资产之溢利(元) 37,458.07------
经营溢利计算(元) -1,530,360,909.77-1,342,432,000.00-192,718,000.00-1,368,742,000.00-856,146,000.00-164,800,000.00131,480,000.00
财务成本(元) 80,288,055.3159,097,000.00-5,809,000.00184,741,000.00214,189,000.00123,245,000.00-9,096,000.00
影响税前利润的其他项目(元) -6,010,892.21--1,939,000.00--4,896,000.00--1,489,000.00
税前利润(元) -1,456,083,746.67-1,283,335,000.00-200,466,000.00-1,184,001,000.00-646,853,000.00-41,555,000.00120,895,000.00
所得税(元) 1,163,820.831,164,000.0030,267,000.00219,244,000.00158,171,000.0057,598,000.00-6,600,000.00
净利润(元) -1,454,919,925.84-1,282,171,000.00-170,199,000.00-964,757,000.00-488,682,000.0016,043,000.00114,295,000.00
 本公司拥有人应占净利润(元) -985,029,654.47-841,429,000.00-139,547,000.00-909,431,000.00-474,411,000.0012,238,000.00121,413,000.00
 非控股权益应占净利润(元) -469,890,271.37-440,742,000.00-30,652,000.00-55,326,000.00-14,271,000.003,805,000.00-7,118,000.00
每股收益
 基本每股收益(元) -3.99-3.41-0.57-3.68-1.920.050.49
 稀释每股收益(元) -3.99-3.41-0.57-3.68-1.920.050.49
其他全面收益(元) 122,813.38147,000.0033,000.00121,000.0056,000.00--
全面收益总额(元) -1,454,797,112.46-1,282,024,000.00-170,166,000.00-964,636,000.00-488,626,000.0016,043,000.00114,295,000.00
 本公司拥有人应占全面收益总额(元) -984,906,841.09-841,282,000.00-139,514,000.00-909,310,000.00-474,355,000.0012,238,000.00121,413,000.00
 非控股权益应占全面收益总额(元) -469,890,271.37-440,742,000.00-30,652,000.00-55,326,000.00-14,271,000.003,805,000.00-7,118,000.00
公告日期 2023-10-302023-09-152023-04-282023-04-172022-10-282022-09-082022-04-28
会计准则 大陆会计准则香港会计准则大陆会计准则香港会计准则大陆会计准则香港会计准则大陆会计准则
审计意见 -------
核数师 -------
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院